Analyst Ratings for Alnylam Pharmaceuticals (ALNY) [Buys]
ALNY Rating Summary
ALNY Price Target Summary
- Highest: $395.00 (H.C. Wainwright)
- Lowest: $150.00 (Cantor Fitzgerald)
- Average: $224.89
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$224.89 (+56.4%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 67%
Avg. $ Target:
$224.89 (+56.4%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 67%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/29/2023 | Raymond James | N/A | New Coverage | Outperform (N/A) |
208.00 (N/A) |
176.86 (143.80) |
-18.69% | Details |
| 5/5/2023 | BMO Capital » Updated 4/8/2024 |
Kostas Biliouris | Upgrade | Outperform (Market Perform) |
234.00 (N/A) |
199.50 (143.80) |
-27.92% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
